Sonidegib-[13C,d3]

Ask the supplier | View on supplier's website

Sonidegib-[13C,d3] is a labelled form of Sonidegib. Sonidegib is an orally bioavailable small-molecule Smoothened (Smo) antagonist with potential antineoplastic activity. It was approved by the FDA for treating basal-cell carcinoma in July 2015.

Supplier	BOC Sciences
Product #	BLP-004258
Pricing	Inquire
Molecular Weight	489.51
Molecular Formula	C25[13C]H23D3F3N3O3

Feedback